Clinical risk management concedes that risk is inherent to all health‐care processes.
Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare but …

PURPOSE: To describe the therapeutic benefits of scleral lenses in the management of
severe ocular surface disease attributable to toxic epidermal necrolysis (TEN) and Stevens …

The diagnosis and management of Stevens-Johnson syndrome is complex and
controversial. Problems in diagnosis and interpretation of published reports result from the …

Purpose: To report the clinical use of ProKera (Bio-Tissue, Inc., Miami, FL) under topical
anesthesia in an outpatient for the management of ocular manifestations of acute Stevens …

PURPOSE: To evaluate the severity of ocular involvement of patients with Stevens-Johnson
syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN overlap, and to investigate …

Objectives To describe the acute and late ocular manifestations of toxic epidermal necrosis
(TEN), Stevens-Johnson syndrome (SJS), and overlap syndrome and to identify predictors …

Purpose: To highlight and compare the outcomes of management for the ocular sequelae of
Stevens–Johnson syndrome (SJS) over 25 years in a tertiary eye care institute. Methods: A …

Aim. To determine the probable causative factors, clinical features, and treatment outcomes
of Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS-TEN …

The literature overwhelmingly describes acute intervention for ocular involvement in
SJS/TEN as improving long-term outcomes. All patients admitted for SJS/TEN or suspicion of …

StevenseJohnson syndrome (SJS) and its more extreme variant, toxic epidermal necrolysis
(TEN), are acute, adverse systemic reactions that can affect anyone who takes medications …